Synthesis and characterization of deoxynivalenol glucuronide: its comparative immunotoxicity with deoxynivalenol.
about
LC-MS/MS-based multibiomarker approaches for the assessment of human exposure to mycotoxinsDeoxynivalenol Exposure Assessment for Pregnant Women in BangladeshT-2 mycotoxin: toxicological effects and decontamination strategiesVulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application.Assessment of deoxynivalenol metabolite profiles in UK adultsHepatic metabolism affects the atropselective disposition of 2,2',3,3',6,6'-hexachlorobiphenyl (PCB 136) in mice.A novel Peptide-binding motifs inference approach to understand deoxynivalenol molecular toxicity.Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in rats.Estimation of multi-mycotoxin contamination in South African compound feeds.Risk Assessment of Deoxynivalenol by Revisiting Its Bioavailability in Pig and Rat Models to Establish Which Is More Suitable.Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice.Effects of milling and cooking processes on the deoxynivalenol content in wheat.In vitro glucuronidation of ochratoxin a by rat liver microsomes.From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol.Oxidative stress-mediated cytotoxicity and metabolism of T-2 toxin and deoxynivalenol in animals and humans: an update.Proposal of a comprehensive definition of modified and other forms of mycotoxins including "masked" mycotoxins.An epimer of deoxynivalenol: purification and structure identification of 3-epi-deoxynivalenol.Deoxynivalenol exposure assessment in young children in Tanzania.Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins.Fast and sensitive LC-MS/MS method measuring human mycotoxin exposure using biomarkers in urine.Deoxynivalenol suppresses circulating and splenic leukocyte subpopulations in BALB/c mice: dose response, time course and sex differences.Synthesis of deoxynivalenol-3-ß-D-O-glucuronide for its use as biomarker for dietary deoxynivalenol exposureDirect quantification of deoxynivalenol glucuronide in human urine as biomarker of exposure to the Fusarium mycotoxin deoxynivalenol
P2860
Q27003329-7D36E82B-B6E0-4DD6-8A45-3CE2B041997BQ28608285-067E3834-F9FB-4F1C-A082-3E31128AE7D2Q33779732-484BD1AD-9595-4236-9909-770605728F9AQ33833674-2AADADAF-0202-43EF-9308-3BC2D35675EDQ34440893-8920E1D8-DC4D-47B2-905E-CCD51CB4B4F9Q34927091-E21DECA3-37DB-44AF-990B-CCA7FD105F9FQ35808563-3D04D52E-8F4E-4E7C-9C05-E2565817B046Q36250222-8BD7B4DC-BC0F-4EA7-B144-E21FAE58E17FQ36395718-B2441355-F4BE-46F5-A56F-4B9DF051A1E7Q36401463-6FD82A5B-0F46-47FF-85CD-B513CB64F6FFQ37050091-272F58D9-2653-4062-AACD-5E9AFB3DFD1FQ37083278-29512B8B-78BC-44BE-95A0-6246622A9E7BQ37416025-C650F27E-2D0A-437D-9DA1-AA880B5B3783Q38101247-B0A7C0CE-0C30-4EB9-8020-20D47A863B8AQ38217411-6B3998FE-30B0-49F3-A57E-019690754545Q39170408-0FB53423-6802-4964-B2D4-94A53532BCA5Q40654939-9A2284CF-02FD-4F26-A213-F2686AC9524AQ43934940-02B3EEA6-A6CC-4876-9586-56F5D8F0EF69Q45206156-374EBE4C-EA7E-4131-85AD-771E36906560Q49047209-2E11387B-C846-4A46-A013-EEC27AEDFBBAQ51620234-EDC2F34F-BB41-4802-A4B8-85FE40ED3E90Q56838911-2E60FE21-751A-4B67-882E-E522F496D9D8Q56838918-BC79A301-99DE-41E0-9CDF-26F4DE9BCFD7
P2860
Synthesis and characterization of deoxynivalenol glucuronide: its comparative immunotoxicity with deoxynivalenol.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Synthesis and characterization ...... otoxicity with deoxynivalenol.
@ast
Synthesis and characterization ...... otoxicity with deoxynivalenol.
@en
type
label
Synthesis and characterization ...... otoxicity with deoxynivalenol.
@ast
Synthesis and characterization ...... otoxicity with deoxynivalenol.
@en
prefLabel
Synthesis and characterization ...... otoxicity with deoxynivalenol.
@ast
Synthesis and characterization ...... otoxicity with deoxynivalenol.
@en
P2093
P1476
Synthesis and characterization ...... otoxicity with deoxynivalenol.
@en
P2093
Joan Cunnick
Patricia Murphy
P304
P356
10.1016/J.FCT.2007.03.018
P577
2007-04-11T00:00:00Z